Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071097
Status:
COMPLETED
Last Update Posted:
2016-09-20
First Post:
2003-10-10
Brief Title:
TMC114-C202 A Study of Safety Efficacy and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients
Sponsor:
Tibotec Pharmaceuticals Ireland
Organization:
Tibotec Pharmaceuticals Ireland
Organization Data
Organization:
Tibotec Pharmaceuticals Ireland
Class:
INDUSTRY
Study ID:
CR006778
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tibotec Pharmaceuticals Ireland
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None